http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013203260-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e75810cb7d022e16fc3e012a68ae090 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf262d450d50046c627f6ce3a0708f91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92fab36adfc98a4dc89ff9666c28c082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_859852aad7bc4fcd24d07df9226719cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b90a8dd214907956065957676bfcd3c |
| publicationDate | 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013203260-A1 |
| titleOfInvention | Screening assays for identifying and validating agents that target cancer stem cells |
| abstract | Described are methods for the identification and validation of agents that target cancer stem cells. Some embodiments include the use of a two-stage method for the identification and validation of selective anti-cancer stem cell 5 agents. Also described are methods for selectively inducing differentiation of a cancer stem cell or reducing the proliferation of a cancer stem cell, and methods that involve determining a level of cancer stem cells from a subject undergoing treatment with an anti-cancer stem cell agent such as dopamine receptor antagonists. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018127055-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110546512-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3566053-A4 |
| priorityDate | 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 704.